Ferrocenes in medicinal chemistry; a personal perspective

We present a short review of some of our recent work mainly targeting cancer-related oncoproteins through the development of primarily novel air- and water-stable iron-based organometallic agents. This work was presented at the recent ISBOMC19 conference at York as an invited lecture.